Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CENGENT THERAPEUTICS EUROPE A/S
A/S
In liquidation
CVR 20293101
Roskildevej 522, 2605
Brøndby
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1997
— employees
Watchlist
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CENGENT THERAPEUTICS EUROPE A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (7)
JP
Jean Pierre Sørensen
Chief Executive Officer
Chief Executive Officer
2001 – 2002
ET
Erik Tronborg Andersen
Audit
Audit
1997 – 1998
HJ
Hanne Jungdal Dannulat
Management
Management
2002 – 2003
OS
Ole Sylvester-Hvid Wiborg
Management
Management
1999 – 2001
JB
Jørgen Bendik Elmer
Unofficial title
Unofficial title
2003 – 2004
BB
Bent Børs Vabø
Management
Management
1998 – 1999
PE
Per Emil Hasselbalch Stakemann
Management
Management
1997 – 1998
Board of directors
Non-executive oversight
Name
Role
Member since
Former (7)
AH
Annemette Heller
Board of Directors
1997 – 1998
PB
Peter Bent Svejgaard Kristensen
Board of Directors
2001 – 2003
KM
Kim Madsen
Chairman
1997 – 1998
SK
Susan Kay Burgess
Board of Directors
1999 – 2000
SH
Steen Helde Hemmingsen
Chairman
1999 – 2001
AG
Arne Gillin
Chairman
2001 – 2001
ET
Edward Thomas Maggio
Board of Directors
1998 – 2003
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CENGENT THERAPEUTICS EUROPE A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network